Holy Basil Figures

6 figures from peer-reviewed research

All 5-HTP Apigenin Ashwagandha CBD GABA Holy Basil Iron Kava Lavender Magnesium Glycinate Melatonin Omega-3 Fatty Acids Passionflower Tryptophan Valerian Root Vitamin B6 Vitamin D Zinc

All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other

Figure 5 Chart

Extended molecular analysis data examining the effects of CBD-rich cannabis extract and MSM on cellular detoxification pathways. The results contribute to understanding the safety implications of co-supplementation.

Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration.

Figure 4. Eﬀects of administration of MSM, CRCE, or MSM/CRCE on intrahepatic expression of cytochrome P450s. Livers were collected 24 h after the last gavage and gene expression was measured using the quantitative real-time (qRT) PCR. Data was analyzed by

Figure 6 Chart

Intrahepatic expression of cytochrome P450 enzymes in response to MSM, CBD-rich cannabis extract (CRCE), or their combination. Alterations in CYP450 expression are critical for assessing drug-supplement interaction potential and metabolic safety.

Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration.

Figure 5. Eﬀects of MSM, CRCE, or MSM/CRCE on intrahepatic synthesis of glutathione and the expression of genes associated with the synthesis of glutathione. (A) Intrahepatic concentrations of total glutathione; (B–D) mRNA levels of (B) Gclm, (C) Gpx1, an

Figure 7 Chart

Effects of MSM, CBD-rich cannabis extract, and their combination on intrahepatic glutathione synthesis and related gene expression. Glutathione is a key antioxidant, and changes in its production may indicate shifts in the liver's oxidative stress response.

Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration.

Figure 6

Isolate Code Oil Degradation (%) PHA Content (%) CDW(g/L)

Bioprospecting and Molecular Identification of Used Transformer Oil-Degrading Bacteria for Bioplastics Production.

Figure 7

Bioprospecting and Molecular Identification of Used Transformer Oil-Degrading Bacteria for Bioplastics Production.

Figure 8

Bioprospecting and Molecular Identification of Used Transformer Oil-Degrading Bacteria for Bioplastics Production.